Short communicationComparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis
Introduction
Since the development of chlorpromazine by Charpentier et al. [1] in 1952 the in vitro antimicrobial activity of this neuroleptic as well as that of others of the phenothiazine series has been frequently demonstrated [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12]. Recently, chlorpromazine and thioridazine have been shown to have activity against multidrug-resistant strains of Mycobacterium tuberculosis [2]. The in vitro activity of phenothiazines takes place at concentrations that exceed those that are clinically achievable. Because phenothiazines are concentrated by macrophages that have phagocytosed mycobacteria and have intracellular activity against mycobacteria [5] we have recommended that the mild phenothiazine, thioridazine, should be employed as an adjuvant for the management of freshly diagnosed infections of M. tuberculosis in patients from areas associated with a high prevalence of MDRTB, at least for the interval during which the antibiotic susceptibility of the isolate is being determined [13]. As this period would be only a few months, side effects associated with the use of neuroleptics are not anticipated. The antimycobacterial activities against MDRTB of commonly employed phenothiazines have not been previously compared in one study.
Section snippets
Phenothiazines
Chlorpromazine (CPZ), thioridazine (THZ), promethazine (PMZ), promazine (PZ) and desipramine (DSP) were purchased from Sigma. Stock solutions and dilutions of each phenothiazine with Bactec 12B medium as the diluent were freshly prepared prior to use in brown flasks and protected from light.
MDRTB strains
The 11 MDRTB strains used in this study came from routine specimens from hospitals in the Lisbon area. The methods used for the isolation, culture, identification and antibiotic susceptibility have been
Results and discussion
The average activity of chlorpromazine, thioridazine, promethazine, promazine and desipramine against 11 MDRTB strains is shown in Fig. 1. Chlorpromazine, a neuroleptic that produces severe and frequent side effects, had the same average activity as the very mild neuroleptic thioridazine. The lowest significant concentration of these two phenothiazines was 1 mg/l and produced an average inhibition of 26% in the amount of 14CO2 produced. At a concentration of 3 mg/l inhibition was 60%. Complete
Acknowledgements
We wish to thank Josefina Almeida and Rosario Bettencourt for their excellent technical assistance during the course of this study.
References (15)
- et al.
Recherches sur les dimethylaminopropyl N-phenothiazines
C. R. Acad. Sci.
(1952) - et al.
Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis
J. Antimicrob. Chemother.
(1996) Contribution a l'etude des properietes antibiotiques de la chlorpromazine ou 4560 RP
Ann. Inst. Pasteur
(1961)- et al.
Antimycobacterial activity of methdilazine (Md): an antimicrobic phenothiazine
Acta Pathol. Micrbiol. Scand.
(1993) - et al.
Chlorpromazine: a drug potentially useful for treating mycobacterial infections
Chemotherapy
(1992) - et al.
In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine
J. Chemother.
(1999) - et al.
The antibacterial effect of selected phenothiazines and thioxanthenes on slow growing mycobacteria
Acta Pathol. Microbiol. Scand. B.
(1986)
Cited by (87)
‘Tethering’ fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase
2018, Bioorganic and Medicinal Chemistry LettersDevelopment of efflux pump inhibitors in antituberculosis therapy
2016, International Journal of Antimicrobial AgentsDesign of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents
2015, European Journal of Medicinal ChemistryAbnormal immune system development and function in schizophrenia helps reconcile diverse findings and suggests new treatment and prevention strategies
2015, Brain ResearchCitation Excerpt :Phenothiazine drugs also exert significant anti-microbial effects (Amaral et al., 2006). Chlorpromazine, for example, exerts bacteriostatic and bactericidal effects against several microorganisms, including Mycobacterium tuberculosis (Amaral et al., 2007; Bettencourt et al., 2000). Thioridazine has been found useful against methicillin-resistant Staphylococcus aureus (Thanacoody, 2007).
SILA-421 activity in vitro against Rifampicin-Susceptible and Rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model
2015, International Journal of Antimicrobial AgentsCitation Excerpt :It has previously been demonstrated that thioridazine (TDZ) used as a TB drug/efflux pump inhibitor (EPI) has in vitro activity. TDZ shows a synergistic effect when combined with isoniazid (INH) and rifampicin (RIF) [3–7]. However, when used in a murine TB model, TDZ showed toxic effects and, moreover, enhanced therapeutic efficacy of the standard TB regimen was not observed [8].
Thioridazine for treatment of tuberculosis: Promises and pitfalls
2014, Tuberculosis